FDA Warning re Misleading Advertising
Folllowing the increased label warning Roche placed advertisements in the media indicating that Accutane could alleviate depression
On 8th March 1998 the FDA sent warning letters to Roche ordering them to withdraw this promotional material, stating they were
‘false and misleading and promote Accutane for an unapproved use’